REPL::Extraordinary/ Special General Meeting::Voluntary

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Security
IX BIOPHARMA LTD. - SG1BD9000009 - 42C

Announcement Details

Announcement Title
Extraordinary/ Special General Meeting
Date &Time of Broadcast
10-Mar-2025 17:40:05
Status
Replacement
Announcement Reference
SG250222XMETBTWB
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Financial Year End
30/06/2025

Event Narrative

Narrative Type
Narrative Text
Additional TextPlease refer to the following attached document:
1. Notice of EGM;
2. Proxy Form; and
3. Circular dated 22 February 2025.
Additional TextThis announcement has been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor").
Additional TextIt has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
Additional TextThe contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.
Additional TextThis replacement announcement is made following the conclusion of the Company's Extraordinary Meeting ("EGM"). Please see attached Results of EGM.

Event Dates

Meeting Date and Time
10/03/2025 10:00:00
Response Deadline Date
07/03/2025 10:00:00

Event Venue(s)

Place
Venue(s)
Venue details
Meeting Venue2 Science Park Drive, Ascent Main Lobby, The Metro, Singapore 118222

Attachments

Related Announcements

Related Announcements

22/02/2025 09:00:15